These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 30015930)

  • 41. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of Overall Survival in Gastric Cancer Using a Nine-lncRNA.
    Cai C; Yang L; Tang Y; Wang H; He Y; Jiang H; Zhou K
    DNA Cell Biol; 2019 Sep; 38(9):1005-1012. PubMed ID: 31335180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma.
    Qi-Dong X; Yang X; Lu JL; Liu CQ; Sun JX; Li C; Wang SG
    Oxid Med Cell Longev; 2020; 2020():6634247. PubMed ID: 33425212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Long Noncoding RNA APOC1P1 as an Oncogene in Clear Cell Renal Cell Carcinoma.
    Sun C; Zhou Z; Shi H; Li F; Zhang G
    Dis Markers; 2019; 2019():2814058. PubMed ID: 31871500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
    Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma.
    Zhao L; Luo H; Dong X; Zeng Z; Zhang J; Yi Y; Lin C
    Medicine (Baltimore); 2022 Sep; 101(39):e30621. PubMed ID: 36181033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosome-related lncRNA score: A value-based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma.
    Yang Z; Zhang X; Zhan N; Lin L; Zhang J; Peng L; Qiu T; Luo Y; Liu C; Pan C; Hu J; Ye Y; Jiang Z; Liu X; Sun M; Zhang Y
    Cancer Med; 2024 Jun; 13(11):e7308. PubMed ID: 38808948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients.
    Zhang M; Zhang J; Liang X; Zhang M
    BMC Med Genomics; 2024 May; 17(1):150. PubMed ID: 38822402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
    Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
    Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of CCNB2 and a novel lncRNAs-related risk model predict prognosis in clear cell renal cell carcinoma.
    Ren C; Wang Q; Xu Z; Pan Y; Wang S; Liu X
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):64. PubMed ID: 38300330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma.
    Cox A; Tolkach Y; Kristiansen G; Ritter M; Ellinger J
    Clin Transl Oncol; 2020 Sep; 22(9):1524-1531. PubMed ID: 31965534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.